A compelling association emerged between the severity of CF and αCGRP levels, with patients exhibiting severe manifestations of the disease demonstrating markedly elevated levels of this neuropeptide compared to those with milder forms of CF. The gene discussed is NPS; the disease is cystic fibrosis.